Temporal changes and clinical significance of peridevice leak following left atrial appendage occlusion with Amplatzer devices

被引:16
|
作者
Korsholm, Kasper [1 ]
Jensen, Jesper M. [1 ]
Norgaard, Bjarne L. [1 ]
Nielsen-Kudsk, Jens E. [1 ]
机构
[1] Aarhus Univ Hosp, Dept Cardiol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark
关键词
CLLA-closure; left atrial appendage; SHDI-structural heart disease intervention; STR-stroke; TTE; TEE; THROMBUS; CLOSURE; IMPACT; ECHOCARDIOGRAPHY; SURVEILLANCE; ANGIOGRAPHY; WATCHMAN; REGISTRY;
D O I
10.1002/ccd.30178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The natural history of peridevice leak (PDL) following left atrial appendage occlusion (LAAO) is unknown. This study sought to investigate changes of PDL from 2 until 12 months after LAAO, using cardiac computed tomography (CT), and to assess the potential association between persistent PDL and clinical outcomes Methods Single-center observational study of Amplatzer LAAO implants between 2010 and 2017 (n = 206). Patients with 2 and 12 months cardiac CT were included in the study (n = 153). Images were blindly analyzed. PDL was characterized by frequency and size at the device disc, lobe, and left atrial appendage contrast patency. Patients were followed for the composite outcome of ischemic stroke, transient ischemic attack, systemic embolism, or all-cause death. Median follow up from LAAO was 3.1 (2.3-4.3) years. Results Contrast patency was present in 101 (66%) and 72 (47%) (p < 0.001) at 2 and 12 months, respectively. PDL was identified at the disc in 103 (67%) patients at 2 months versus 93 (61%) at 12 months (p = 0.08), and at the lobe in 29 (19%) at both time points. PDL area at the disc did not change significantly over time, increment $\unicode{x02206}$ area: -8.95 mm (95% confidence interval [CI]: -18.9; 1.01) p = 0.08. Permanent atrial fibrillation was independently associated with persistent PDL. Persistent versus no PDL was associated with a 62% worse clinical outcome, however not statistically significant, hazard ratio (HR): 1.62 (95% CI: 0.9-2.93), p = 0.11. Conclusion Persistent PDL was frequently observed following LAAO with Amplatzer devices. The PDL frequency and size appeared unchanged between 2 and 12 months. Persistent PDL was not significantly associated with worse clinical outcomes, yet this needs further delineation in future studies.
引用
收藏
页码:2071 / 2079
页数:9
相关论文
共 50 条
  • [41] Left atrial appendage occlusion with the Amplatzer Amulet: update on device sizing
    Freixa, Xavier
    Aminian, Adel
    Tzikas, Apostolos
    Saw, Jacqueline
    Nielsen-Kudsk, Jens-Erick
    Ghanem, Alexander
    Schmidt, Boris
    Hildick-Smith, David
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2020, 59 (01) : 71 - 78
  • [42] Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure
    Dukkipati, Srinivas R.
    Holmes, David R.
    Doshi, Shephal K.
    Kar, Saibal
    Singh, Sheldon M.
    Gibson, Douglas
    Price, Matthew J.
    Natale, Andrea
    Mansour, Moussa
    Sievert, Horst
    Houle, Vicki M.
    Allocco, Dominic J.
    Reddy, Vivek Y.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (05) : 469 - 483
  • [43] PERIDEVICE LEAK AND DEVICE SIZING IN PATIENTS RECEIVING LEFT ATRIAL APPENDAGE CLOSURE WITH THE WATCHMAN DEVICE
    Ranard, Lauren Sharan
    Donald, Elena
    Chen, Shmuel
    Khalique, Omar
    Hamid, Nadira
    Hahn, Rebecca
    Ali, Ziad
    Ng, Vivian
    Forman, Jessica
    Flattery, Erin
    Rahim, Hussein
    Cahill, Thomas
    Sharma, Anjali
    Nemshah, Yaser
    Leon, Martin
    Sommer, Robert
    Vahl, Torsten
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 955 - 955
  • [44] One-year permeability rate of left atrial appendage closure devices: high incidence of peridevice leak and lack of endothelialization
    Laugaudin, G.
    Granier, M.
    Massin, F.
    Cade, S.
    Cransac, F.
    Ricci, J. E.
    Freitag, C.
    Vernhet-Kovacsik, H.
    Pasquie, J. L.
    EUROPEAN HEART JOURNAL, 2016, 37 : 500 - 500
  • [45] Percutaneous left atrial appendage occlusion with Amplatzer devices in high risk patients with atrial fibrillation and a contraindication to oral anticoagulation
    Nielsen, K. M.
    Jensen, J. M.
    Andersen, G.
    Nielsen-Kudsk, J. E.
    EUROPEAN HEART JOURNAL, 2014, 35 : 973 - 973
  • [46] Transcatheter left atrial appendage occlusion in atrial fibrillation: comparison of non-dedicated versus dedicated amplatzer devices
    Gloekler, S.
    Schmid, M.
    Saguner, A. A.
    Khattab, A. A.
    Wahl, A.
    Wenaweser, P.
    Windecker, S.
    Meier, B.
    EUROPEAN HEART JOURNAL, 2011, 32 : 667 - 667
  • [47] Transcatheter left atrial appendage occlusion in atrial fibrillation: comparison of non-dedicated versus dedicated amplatzer devices
    Gloekler, S.
    Schmid, M.
    Saguner, A. A.
    Khattab, A. A.
    Wahl, A.
    Wenaweser, P.
    Windecker, S.
    Meier, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 667 - 667
  • [48] Safety and effectiveness of transcatheter leak occlusion with detachable coils following left atrial appendage closure
    Della Rocca, D. G.
    Horton, R. P.
    Gasperetti, A.
    Di Biase, L.
    Mohanty, S.
    Natale, V. N.
    Trivedi, C.
    Bassiouny, M.
    Al-Ahmad, A.
    Gianni, C.
    Burkhardt, J. D.
    Gallinghouse, G. J.
    Romero, J.
    Sanchez, J.
    Natale, A.
    EUROPEAN HEART JOURNAL, 2019, 40 : 596 - 596
  • [49] First Experience of Transcatheter Leak Occlusion With Detachable Coils Following Left Atrial Appendage Closure
    Della Rocca, Domenico G.
    Horton, Rodney P.
    Di Biase, Luigi
    Bassiouny, Mohamed
    Al-Ahmad, Amin
    Mohanty, Sanghamitra
    Gasperetti, Alessio
    Natale, Veronica N.
    Trivedi, Chintan
    Gianni, Carola
    Burkhardt, J. David
    Gallinghouse, G. Joseph
    Hranitzky, Patrick
    Sanchez, Javier E.
    Natale, Andrea
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (03) : 306 - 319
  • [50] Left atrial appendage occlusion: basic and clinical
    Zhang, Nan
    Su, Wilber
    Li, Yuxin
    Song, Junxian
    Liu, Tong
    Xie, Ruiqin
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10